JP2009538336A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538336A5
JP2009538336A5 JP2009512260A JP2009512260A JP2009538336A5 JP 2009538336 A5 JP2009538336 A5 JP 2009538336A5 JP 2009512260 A JP2009512260 A JP 2009512260A JP 2009512260 A JP2009512260 A JP 2009512260A JP 2009538336 A5 JP2009538336 A5 JP 2009538336A5
Authority
JP
Japan
Prior art keywords
group
substituted
unsubstituted
compound
glucosidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009512260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009538336A (ja
JP5241709B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/069448 external-priority patent/WO2007140184A2/en
Publication of JP2009538336A publication Critical patent/JP2009538336A/ja
Publication of JP2009538336A5 publication Critical patent/JP2009538336A5/ja
Application granted granted Critical
Publication of JP5241709B2 publication Critical patent/JP5241709B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009512260A 2006-05-24 2007-05-22 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法 Expired - Fee Related JP5241709B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80277606P 2006-05-24 2006-05-24
US60/802,776 2006-05-24
PCT/US2007/069448 WO2007140184A2 (en) 2006-05-24 2007-05-22 Deoxynojirimycin and d-arabinitol analogs and methods of using

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013039548A Division JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Publications (3)

Publication Number Publication Date
JP2009538336A JP2009538336A (ja) 2009-11-05
JP2009538336A5 true JP2009538336A5 (enExample) 2010-07-01
JP5241709B2 JP5241709B2 (ja) 2013-07-17

Family

ID=38779322

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009512260A Expired - Fee Related JP5241709B2 (ja) 2006-05-24 2007-05-22 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法
JP2013039548A Pending JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013039548A Pending JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Country Status (8)

Country Link
US (1) US8975280B2 (enExample)
EP (1) EP2023927B1 (enExample)
JP (2) JP5241709B2 (enExample)
CN (2) CN104876855A (enExample)
CA (1) CA2652958C (enExample)
ES (1) ES2537572T3 (enExample)
HK (1) HK1214261A1 (enExample)
WO (1) WO2007140184A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2049126A2 (en) * 2006-08-02 2009-04-22 United Therapeutics Corporation Liposome treatment of viral infections
US20090252785A1 (en) * 2008-03-26 2009-10-08 University Of Oxford Endoplasmic reticulum targeting liposomes
EP2398321B1 (en) * 2009-02-23 2015-11-25 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
CA2753194A1 (en) * 2009-02-24 2010-09-02 United Therapeutics Corporation Iminosugars and methods of treating arenaviral infections
KR20120059447A (ko) * 2009-03-27 2012-06-08 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 콜레스테롤 수준 저하 리포좀
US20100248365A1 (en) * 2009-03-27 2010-09-30 Zacharon Pharmaceuticals, Inc. Ganglioside biosynthesis modulators
CN102639133B (zh) * 2009-06-12 2015-03-11 联合治疗公司 亚氨基糖和治疗布尼亚病毒性疾病以及披膜病毒性疾病的方法
JP5752689B2 (ja) 2009-09-04 2015-07-22 ユナイテッド セラピューティクス コーポレイション フィロウイルス疾患を治療するイミノ糖および方法
US20110065752A1 (en) * 2009-09-04 2011-03-17 United Therapeutics Corporation Methods of treating orthomyxoviral infections
CA2772807A1 (en) * 2009-09-04 2011-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Methods of treating poxviral infections
JP2015518896A (ja) 2012-06-06 2015-07-06 ユニザー ヴィロロジー,エルエルシー 新規イミノ糖およびそれらの用途
EP2968300A4 (en) 2013-03-15 2016-09-28 Unither Virology Llc ANTIBACTERIAL COMPOUNDS
US20160075651A1 (en) * 2013-05-02 2016-03-17 Unither Virology, Llc Glycolipid inhibition using iminosugars
EP3046558B1 (en) 2013-09-16 2019-08-14 Emergent Virology LLC Deoxynojirimycin derivatives and methods of their using
US10428022B2 (en) 2014-11-05 2019-10-01 Emergent Virology Llc Iminosugars useful for the treatment of viral diseases
EP3318277A1 (en) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
GB2020278B (en) 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
JPS5943947B2 (ja) * 1978-05-03 1984-10-25 日本新薬株式会社 N−置換モラノリン誘導体
JPS5943949B2 (ja) 1978-09-29 1984-10-25 日本新薬株式会社 モラノリンのn−置換誘導体
JPS5943948B2 (ja) * 1978-07-06 1984-10-25 日本新薬株式会社 置換モラノリン誘導体
DE3007078A1 (de) 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
DE3024901A1 (de) 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
DE3620645A1 (de) 1985-12-20 1987-07-02 Bayer Ag 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
JPS62155291A (ja) 1985-12-20 1987-07-10 バイエル・アクチエンゲゼルシヤフト 3−アミノ−4,5−ジヒドロキシピペリジン類、それらの製造方法及びそれらの使用
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel
US4985445A (en) 1988-02-12 1991-01-15 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitors and novel compounds
JPH0643306B2 (ja) * 1988-02-12 1994-06-08 明治製菓株式会社 癌細胞転移抑制剤
EP0350012A3 (en) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
ES2086323T3 (es) * 1988-11-03 1996-07-01 Searle & Co Derivados del didesoxi-arabinitol como compuestos antiviricos.
US5256788A (en) 1989-02-13 1993-10-26 Nippon Shinyaku Co. Ltd. Moranoline derivatives and their production and the use of moranoline and its derivatives as a stabilizing agent for enzymes
JPH0675510B2 (ja) 1989-02-13 1994-09-28 日本新薬株式会社 モラノリン誘導体の製法
US5051401A (en) * 1989-04-07 1991-09-24 University Of South Alabama Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
DE4009561A1 (de) 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
WO1992000277A1 (en) 1990-06-29 1992-01-09 Nippon Shinyaku Co., Ltd. Piperidine derivative
US5290948A (en) 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
PT739205E (pt) 1994-01-13 2000-04-28 Monsanto Co Utilizacao de derivados de 1,5-didesoxi-1,5-imino-d-glucitol para o tratamento de infeccoes com o virus da hepatite b
WO1995022975A1 (en) 1994-02-25 1995-08-31 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
ES2216327T3 (es) 1997-11-10 2004-10-16 G.D. SEARLE & CO. Uso de iminoazucares alquilados para tratar la resistencia a multiples a farmacos.
DE69932154T2 (de) 1998-02-12 2007-05-31 G.D. Searle Llc, Chicago Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
EP1261339A1 (en) 2000-02-14 2002-12-04 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
CA2479027A1 (en) * 2002-03-13 2003-09-18 Aarnoud C. Van Der Spoel A non-hormonal approach to male contraception
JP4585851B2 (ja) * 2002-07-17 2010-11-24 アクテリオン ファーマシューティカルズ リミテッド グルコシルセラミドシンターゼの阻害剤としてのピペリジントリオール誘導体
JP2008545657A (ja) 2005-05-17 2008-12-18 アミカス セラピューティックス インコーポレイテッド 1−デオキシノジリマイシンおよび誘導体を用いるポンペ病の治療方法

Similar Documents

Publication Publication Date Title
JP2009538336A5 (enExample)
JP2006520339A5 (enExample)
JP2010536766A5 (enExample)
JP2010511721A5 (enExample)
JP2004536811A5 (enExample)
JP2007511546A5 (enExample)
JP2009535462A5 (enExample)
JP2013507423A5 (enExample)
JP2007523139A5 (enExample)
JP2010534247A5 (enExample)
IN2006DE01793A (enExample)
JP2012532135A5 (enExample)
JP2012510502A5 (enExample)
JP2006502283A5 (enExample)
JP2010525122A5 (enExample)
MY150047A (en) Method of producing 2'-deoxy-5-azacytidine (decitabine)
JP2010524927A5 (ja) 化合物2−ヒドロキシ−3−[5−(モルホリン−4−イルメチル)ピリジン−2−イル]1h−インドール−5−カルボニトリルの新規な製造方法
JP2005536519A5 (enExample)
DE60326819D1 (de) Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase
JP2009184932A5 (enExample)
JP2008201774A5 (enExample)
JP2012503653A5 (enExample)
JP2009541414A5 (enExample)
JP2006518765A5 (enExample)
JP2004538278A5 (enExample)